Stay updated on Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial
Sign up to get notified when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.

Latest updates to the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded the latest site revision banner: Revision: v3.4.2, and removed older notices including the funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary is now available. The page includes a new 'Last Update Submitted that Met QC Criteria' label, updated capitalization for 'No FEAR Act Data', and the revision tag changed from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page version was updated from v3.3.3 to v3.3.4; there are no changes to the study details, locations, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded the Locations section and updated to Revision v3.3.3; removed HHS Vulnerability Disclosure, Migration Data Locations, and Revision v3.3.2.SummaryDifference0.2%

- Check92 days agoChange DetectedFooter metadata updated from Revision v3.2.0 to v3.3.2. This is a minor metadata update and does not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.